Why Calumet Stock Is Rocketing Higher Today
Key Points
Bank of America raised its price target on Calumet stock.
Stronger free cash flow enabled the company to retire debt in Q2 2026.
- 10 stocks we like better than Calumet ›
After a 6.8% decline last week, shares of Calumet (NASDAQ: CLMT) are racing higher today. With an analyst taking a more bullish stance on Calumet stock, investors have been motivated to pick up shares of the renewable fuels producer.
As of 2:36 p.m. ET, Calumet stock is up 15.2%.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Image source: Getty Images.
Free cash flow figures prominently into this new opinion
Maintaining a buy rating, Bank of America lifted its price target on Calumet stock to $45 from $38. According to Thefly.com, the firm based its more bullish price target on the recognition that Calumet is strengthening its balance sheet through stronger free cash flow, which is helping the company to retire debt.
Based on Calumet's Friday closing price of $39.48, the new Bank of America price target implies 14% upside.
Calumet generated about $54 million in free cash flow during Q2 2026. This supported the company's retiring $115 million in debt last month.
Efforts to continue strengthening the company's financial health by shoring up its balance sheet may extend into future quarters. In its Q2 2026 financial results press release, Calumet states that it "remains focused on strong operations and continued use of cash from operations to pay down debt in future periods."
What's an investor to do now?
While Bank of America's higher price target for Calumet is worth acknowledging, investors should recognize that the stock is hardly a screaming buy right now. Shares have soared 127% year-to-date as of this writing, and they're still priced at a premium to their five-year average price-to-sales multiple of 0.33, trading currently at 0.75 times sales. Fortunately for those with a hankering for a chemical stock investment, there are plenty of other choices to consider.
Should you buy stock in Calumet right now?
Before you buy stock in Calumet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Calumet wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $399,832!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,374,595!*
Now, it’s worth noting Stock Advisor’s total average return is 968% — a market-crushing outperformance compared to 215% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 10, 2026.
Bank of America is an advertising partner of Motley Fool Money. Scott Levine has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Recommended Articles
